WHO ICTRP trial

comparative study of methyprednisolone and sphenopalatine block in spinal…

CTRI/2024/06/068282 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2024/06/068282
Public title comparative study of methyprednisolone and sphenopalatine block in spinal headache after obstretrics and gynecological surgery
Scientific title A study to compare efficacy of oral methylprednisolone and sphenopalatine block in postdural puncture headache - NIL
Primary sponsor Dr Mohd Rasheed
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Conditions Health Condition 1: O894- Spinal and epidural anesthesia-induced headache during the puerperium
Interventions Intervention1: Methylprednisolone: Methylprednisolone 8 mg OD for 5 days Control Intervention1: Sphenopalatine block: Sphenopalatine block with Bupivacaine 2% intranasal route sos with maximum three times a day for 5 days
Registration date Apr 6, 2024
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations